Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inetetamab”

24 trials

Showing 20 of 24 results

Testing effectiveness (Phase 2)Study completedNCT05444998
What this trial is testing

Neoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 20
Not applicableStudy completedNCT06305702
What this trial is testing

Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast Cancer
Liaoning Cancer Hospital & Institute 500
Testing effectiveness (Phase 2)UnknownNCT05823623
What this trial is testing

Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Not applicableUnknownNCT06015100
What this trial is testing

Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

Who this might be right for
Breast Cancer
Yan Xue 40
Not applicableLooking for participantsNCT06234137
What this trial is testing

A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer

Who this might be right for
Breast Neoplasm Female
Wang Ouchen 154
Large-scale testing (Phase 3)Not Yet RecruitingNCT04736589
What this trial is testing

Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway

Who this might be right for
Breast Cancer
Peking Union Medical College 270
Not applicableUnknownNCT05764941
What this trial is testing

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)UnknownNCT05749016
What this trial is testing

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Who this might be right for
Locally Advanced Breast CancerChemotherapy Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableStudy completedNCT06990347
What this trial is testing

A Study on the Efficacy and Safety of IPyC for HER2+ MBC

Who this might be right for
Breast Cancer
Fujian Medical University 301
Testing effectiveness (Phase 2)UnknownNCT04681287
What this trial is testing

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

Who this might be right for
HER2 Positive Metastatic Breast Cancer
Henan Cancer Hospital 46
Not applicableNot Yet RecruitingNCT05980208
What this trial is testing

A Real-world Study of Inetetamab for First-line Treatment of MBC

Who this might be right for
Breast CancerReal-world Study
Hunan Cancer Hospital 150
Testing effectiveness (Phase 2)UnknownNCT05621434
What this trial is testing

Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Recurrent/Metastatic Breast Cancer
Fujian Medical University 63
Testing effectiveness (Phase 2)UnknownNCT04681911
What this trial is testing

Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 71
Testing effectiveness (Phase 2)UnknownNCT04963595
What this trial is testing

Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Zhiyong Yu 100
Post-approval studies (Phase 4)UnknownNCT05291910
What this trial is testing

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)UnknownNCT05016544
What this trial is testing

Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 48
Not applicableLooking for participantsNCT05856383
What this trial is testing

Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC

Who this might be right for
HER2-positive Advanced Breast Cancer
Zhejiang Cancer Hospital 100
Not applicableUnknownNCT04963608
What this trial is testing

RWS of Inetetamab HER2 Positive Advanced Breast Cancer

Who this might be right for
HER2-positive Advanced Breast Cancer
Zhiyong Yu 100
Post-approval studies (Phase 4)Looking for participantsNCT06641544
What this trial is testing

The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 200
Testing effectiveness (Phase 2)UnknownNCT04941885
What this trial is testing

Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 78
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation